NovaBay Pharma (NBY) Misses Q3 EPS by 18c

November 10, 2016 4:27 PM EST

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

NovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.34), $0.18 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.4 million versus the consensus estimate of $3.02 million.

For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment